D. Gwyn Bebb

1.7k total citations
48 papers, 1.2k citations indexed

About

D. Gwyn Bebb is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, D. Gwyn Bebb has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in D. Gwyn Bebb's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and DNA Repair Mechanisms (10 papers). D. Gwyn Bebb is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and DNA Repair Mechanisms (10 papers). D. Gwyn Bebb collaborates with scholars based in Canada, United States and United Kingdom. D. Gwyn Bebb's co-authors include Susan P. Lees‐Miller, Chris T. Williamson, Huong Muzik, Michelle L. Dean, Ruiqiong Ye, Nicholas Jette, Eiji Kubota, Alberto Zamò, Mark J. O’Connor and Ali G. Turhan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

D. Gwyn Bebb

46 papers receiving 1.2k citations

Peers

D. Gwyn Bebb
D. Gwyn Bebb
Citations per year, relative to D. Gwyn Bebb D. Gwyn Bebb (= 1×) peers Geraldine O’Sullivan Coyne

Countries citing papers authored by D. Gwyn Bebb

Since Specialization
Citations

This map shows the geographic impact of D. Gwyn Bebb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gwyn Bebb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gwyn Bebb more than expected).

Fields of papers citing papers by D. Gwyn Bebb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gwyn Bebb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gwyn Bebb. The network helps show where D. Gwyn Bebb may publish in the future.

Co-authorship network of co-authors of D. Gwyn Bebb

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gwyn Bebb. A scholar is included among the top collaborators of D. Gwyn Bebb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gwyn Bebb. D. Gwyn Bebb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pundole, Xerxes, Akhila Balasubramanian, Erik S. Anderson, et al.. (2024). Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancer. The Oncologist. 29(12). 1079–1089. 6 indexed citations
2.
Bebb, D. Gwyn, et al.. (2023). Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers. Pulmonary Therapy. 9(3). 435–450. 6 indexed citations
3.
Gibson, Adam, Daniel E. Meyers, Michael Dean, et al.. (2021). P16.03 Early Mortality Associated Factors With Immune Checkpoint Inhibition in Real-World Canadian NSCLC Patients. Journal of Thoracic Oncology. 16(3). S348–S348.
4.
Fung, Andrea S., Karen Kopciuk, Michelle L. Dean, et al.. (2021). CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients. PLoS ONE. 16(1). e0241240–e0241240. 6 indexed citations
5.
Lewinson, Ryan T., Daniel E. Meyers, Isabelle A. Vallerand, et al.. (2020). Machine learning for prediction of cutaneous adverse events in patients receiving anti–PD-1 immunotherapy. Journal of the American Academy of Dermatology. 84(1). 183–185. 14 indexed citations
8.
Wang, Chen, et al.. (2017). ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib. Translational Oncology. 10(2). 190–196. 96 indexed citations
9.
D’Silva, Adrijana, Alain Tremblay, Paul MacEachern, et al.. (2017). Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients. PLoS ONE. 12(8). e0181867–e0181867. 8 indexed citations
10.
Bebb, D. Gwyn, et al.. (2017). P1.02-086 ATM Mutations in Lung Cancer Correlate to Higher Mutation Rates. Journal of Thoracic Oncology. 12(1). S541–S541. 2 indexed citations
11.
Kopciuk, Karen, et al.. (2016). Addressing disease progression in EGFRmut+ NSCLC patients. Annals of Oncology. 27. vi432–vi432. 1 indexed citations
12.
Hao, Desirée, et al.. (2016). Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment. Metabolomics. 12(3). 58–58. 60 indexed citations
13.
Radhakrishnan, Sarvan Kumar, D. Gwyn Bebb, & Susan P. Lees‐Miller. (2013). Targeting ataxia-telangiectasia mutated deficient malignancies with poly ADP ribose polymerase inhibitors. Translational Cancer Research. 2(3). 155–162. 5 indexed citations
14.
Klimowicz, Alexander C., Karen Kopciuk, Stephanie Petrillo, et al.. (2011). CXCR4 Overexpression Is Associated with Poor Outcome in Females Diagnosed with Stage IV Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(7). 1169–1178. 60 indexed citations
15.
Williamson, Chris T., Huong Muzik, Ali G. Turhan, et al.. (2010). ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors. Molecular Cancer Therapeutics. 9(2). 347–357. 147 indexed citations
16.
Williamson, Chris T., D. Gwyn Bebb, Karl Riabowol, et al.. (2010). The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status. Oncogene. 29(27). 3990–3996. 50 indexed citations
17.
Bebb, D. Gwyn, et al.. (2009). Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life. BMC Gastroenterology. 9(1). 60–60. 39 indexed citations
18.
Bebb, D. Gwyn, Gary de Jong, Zhe Yu, et al.. (2001). Radiation induced apoptosis in ataxia telangiectasia homozygote, heterozygote and normal cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 476(1-2). 13–20. 12 indexed citations
19.
Bebb, D. Gwyn, Jinxin Chen, Milhan Telatar, et al.. (1999). Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer. British Journal of Cancer. 80(12). 1979–1981. 40 indexed citations
20.
Bebb, D. Gwyn, et al.. (1998). Caffeine does not potentiate γ-radiation induced DNA damage in ataxia telangiectasia lymphoblastoid cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 401(1-2). 27–32. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026